FELISHA KIEHL: Open Payments
NPI 1235692500 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 42 payments from 11 companies in 2025. Trend: 2023 $289 · 2024 $443 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 24 | $211 |
| Endo USA, Inc. | 4 | $163 |
| UROGEN PHARMA, INC. | 3 | $84 |
| Janssen Biotech, Inc. | 1 | $69 |
| 180 Medical, Inc. | 2 | $56 |
| Fennec Pharmaceuticals, Inc. | 1 | $55 |
| Boston Scientific Corporation | 1 | $47 |
| ABC Home Medical Supply, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $33 |
| Teleflex LLC | 1 | $20 |
Products named: GEMTESA, XIAFLEX, JELMYTO, RYBREVANT, AVEED, Fyarro, Axonics, LUPRON DEPOT.
Industry payments across IN — which companies pay providers there.
